PROFILE: Can Molecular Biomarkers Predict Outcomes to Crohn’s Disease Treatment? Evidence-Based GI: An ACG Publication and Podcast
-
- Medicine
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Bharati Kochar, MD, MS discuss “A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn’s disease (PROFILE): a multicentre, open-label randomised controlled trial,” by Noor NM et al. Lancet Gastroenterol Hepatol. 2024; 9: 415-27.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Bharati Kochar, MD, MS discuss “A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn’s disease (PROFILE): a multicentre, open-label randomised controlled trial,” by Noor NM et al. Lancet Gastroenterol Hepatol. 2024; 9: 415-27.
22 min